|
35587536 |
0 |
Popov J, Coelho S, Carrier M, et al.
Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study.
J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760.
|
|
28160670 |
0 |
Coyle K, Carrier M, Lazo-Langner A, et al.
Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25.
|
|
26817957 |
0 |
Ihaddadene R, Corsi DJ, Lazo-Langner A, et al.
Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.
Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27.
|
|
26095467 |
0 |
Carrier M, Lazo-Langner A, Shivakumar S, et al.
Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.
|
, McMaster University